Monogenic Autoinflammatory Diseases Registry


The purpose of the Monogenic Autoinflammatory Diseases Registry is to collate data to facilitate clinical service planning and to inform clinical best practice. The Registry will also enable research on aggregated data and the identification of eligible volunteers for clinical trials.


To facilitate service planning by analyses and reporting of data collected by the Registry on prevalence, geographical distribution, genetic variants associated with disease, clinical features, clinical management and patient outcomes.

To enable research by providing aggregate, de-identified data to research entities.

To facilitate identification and recruitment of eligible volunteers for clinical trials.

To promulgate new knowledge to inform best practice and care services.

Administration and Oversight

The Monogenic Autoinflammatory Diseases Registry is governed by a National Advisory Board. The Board includes representatives from each partner and will oversee all registry activities including all enquiries for access.

The AIDA Project website is available for more information.


For more information on the Monogenic Autoinflammatory Diseases Registry, please contact

Please log in by clicking on the link located in the top-right corner